While focusing on 12 key government policy areas, the Review, which is distributed to Policymakers in the UK and abroad, allows leading organisations and executives to share personal insight as well as discuss good practice alongside Cabinet and senior ministers.
Abingdon, whose core expertise lies in the development and manufacturing of immunoassay tests and reader systems, has been chosen to represent the rapid diagnostics testing industry.
Abingdon Health is included within the 2016/2017 Healthcare Parliamentary Review which includes Forwards from The Right Honourable Theresa May MP, Prime Minister, Luciana Berg MP, Member of the Health Select Committee and Niall Dickson, Chief Executive of the NHS Confederation.
In the Review, Abingdon Health Chief Executive Office, Chris Yates, offers insight into the growth of the diagnostics industry, outlines Abingdon’s strategy as well discusses the factors he believes have driven the success of Abingdon to date, including a focus on building an open, collaborative culture, investment in automation and innovation and a continual focus on quality improvement.
To read Abingdon Health’s entry in the Parliamentary Review 2017 (pages 32 – 34) visit https://www.theparliamentaryreview.co.uk/editions/healthcare/healthcare